SEC Form 4 · accession 0001213900-18-000338
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Brigham
Officer — President & CEO · Director
Period of report
Jan 8, 2018
Accepted (ET)
Jan 10, 2018 · 9:15 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Options (Right to buy) | $7.80 | Jan 8, 2018 | A | 20,000 | D | Jan 8, 2021 | Jan 8, 2028 | Common Stock | 20,000 | 20,000 | D |